69 related articles for article (PubMed ID: 271271)
1. Cellular distribution of hemoglobin F in a clonal hemopoietic stem-cell disorder.
Papayannopoulou T; Bunn HF; Stamatoyannopoulos G
N Engl J Med; 1978 Jan; 298(2):72-5. PubMed ID: 271271
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
Baudin V; Pagnier J; Labie D; Girot R; Wajcman H
Haematologia (Budap); 1986; 19(3):177-84. PubMed ID: 2430866
[TBL] [Abstract][Full Text] [Related]
3. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
[TBL] [Abstract][Full Text] [Related]
4. Cells on stems.
Desforges JF
N Engl J Med; 1978 Jan; 298(2):104. PubMed ID: 271269
[No Abstract] [Full Text] [Related]
5. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
[TBL] [Abstract][Full Text] [Related]
6. Fetal hemoglobin analysis of erythroid bursts in patients with chronic myelogenous leukemia (CML).
Strobel ES; Messner HA; Löhr GW; Fauser AA
Exp Hematol; 1983 Nov; 11(10):982-6. PubMed ID: 6198197
[TBL] [Abstract][Full Text] [Related]
7. Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells.
Fialkow PJ; Denman AM; Jacobson RJ; Lowenthal MN
J Clin Invest; 1978 Oct; 62(4):815-23. PubMed ID: 308953
[TBL] [Abstract][Full Text] [Related]
8. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
[TBL] [Abstract][Full Text] [Related]
9. Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation.
Fialkow PJ; Singer JW; Adamson JW; Berkow RL; Friedman JM; Jacobson RJ; Moohr JW
N Engl J Med; 1979 Jul; 301(1):1-5. PubMed ID: 286882
[TBL] [Abstract][Full Text] [Related]
10. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
[TBL] [Abstract][Full Text] [Related]
11. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
[TBL] [Abstract][Full Text] [Related]
12. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
13. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
[TBL] [Abstract][Full Text] [Related]
15. Regulation of fetal hemoglobin production.
Kazazian HH
Semin Hematol; 1974 Oct; 11(4):525-48. PubMed ID: 4608465
[No Abstract] [Full Text] [Related]
16. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
[TBL] [Abstract][Full Text] [Related]
17. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type.
Nagel RL; Fabry ME; Pagnier J; Zohoun I; Wajcman H; Baudin V; Labie D
N Engl J Med; 1985 Apr; 312(14):880-4. PubMed ID: 2579336
[TBL] [Abstract][Full Text] [Related]
18. Individual variation in the production and survival of F cells in sickle-cell disease.
Dover GJ; Boyer SH; Charache S; Heintzelman K
N Engl J Med; 1978 Dec; 299(26):1428-35. PubMed ID: 101847
[TBL] [Abstract][Full Text] [Related]
19. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
[TBL] [Abstract][Full Text] [Related]
20. Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes.
Dover GJ; Boyer SH; Zinkham WH
J Clin Invest; 1979 Feb; 63(2):173-6. PubMed ID: 429549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
